ロード中...
MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury
Spinal cord injury (SCI) is a serious condition that affects bodily function; however, there is no effective therapy in clinical practice. MCC950, a selective NOD-like receptor protein-3 (NLRP3) inflammasome inhibitor, has been reported to alleviate canonical and non-canonical NLRP3 inflammasome act...
保存先:
| 出版年: | Front Mol Biosci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7062868/ https://ncbi.nlm.nih.gov/pubmed/32195267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.00037 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|